SM Energy Co. (0KZA)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 39.28 |
|---|---|
| 52-week range | 17.09 – 41.55 |
| Return, 1 month / 3 months | +5.8% / +24.4% |
| Return, 1 year / 3 years | +81.3% / +11.3% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 50.6% |
| Worst drawdown (1 year) | -24.8% |
| Average daily value traded | 0.26M USD |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SM Energy Co. is an independent energy company that explores for and produces oil and natural gas. Its operations centre on unconventional shale resources in the Permian Basin of west Texas and the Eagle Ford formation in south Texas, where it drills horizontal wells. The company sells crude oil, natural gas liquids and natural gas to refiners, midstream operators and other energy buyers. It is based in Denver, Colorado, in the United States.
On this site SM Energy Co. appears as a stock on the London Exchange (UK), code 0KZA, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SM Energy Co. (0KZA) trades on the London Exchange in UK. It last closed at USD 39.28 on 19 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 543 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 81.3% and over the last three months it rose 24.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 35.8% | ||
| From 52-week high | -5.1% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.4% | ||
| 6-month return | 42.6% | ||
| 12-month return, skipping the last month | 71.3% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.8% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.26M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +5.8% |
| 3 months | +24.4% |
| 6 months | +42.6% |
| 1 year | +81.3% |
| 3 years | +11.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 36.05 / 28.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Sep 2026 | USD 0.2200 |
| 8 Jun 2026 | USD 0.2200 |
| 6 Mar 2026 | USD 0.2200 |
| 24 Dec 2025 | USD 0.2000 |
| 16 Oct 2025 | USD 0.2000 |
| 18 Jul 2025 | USD 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.